Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Vaxart Q4 2023 GAAP EPS $(0.12) Beats $(0.14) Estimate, Sales $3.245M Beat $1.250M Estimate

Author: Benzinga Newsdesk | March 14, 2024 04:10pm
Vaxart (NASDAQ:VXRT) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.14) by 14.29 percent. This is a 33.33 percent increase over losses of $(0.18) per share from the same period last year. The company reported quarterly sales of $3.245 million which beat the analyst consensus estimate of $1.250 million by 159.60 percent. This is a 14.65K percent increase over sales of $22.000 thousand the same period last year.

Posted In: VXRT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist